07:00 , Jul 4, 2011 |  BioCentury  |  Finance

Analyst tracks

Analyst tracks Mani Mohindru and James Molloy joined ThinkEquity as senior research analysts. Mohindru will focus on biotechnology, while Molloy will focus on specialty pharmaceuticals and biotechnology. Mohindru was a managing partner at Axon Healthcare...
08:00 , Jan 3, 2011 |  BC Week In Review  |  Financial News

Oragenics withdraws follow-on

Oragenics Inc. (OTCBB:ORNI), Alachua, Fla.   Business: Dental, Infectious, Diagnostic   Date announced: 12/22/10   Type: Follow-on   Underwriters: ThinkEquity; Caris & Co.  ...
07:00 , Aug 30, 2010 |  BC Week In Review  |  Financial News

Oragenics proposes follow-on

Oragenics Inc. (OTCBB:ORNI), Alachua, Fla.   Business: Dental, Infectious, Diagnostic   Date announced: 8/25/10   Type: Follow-on   To be raised: Up to $23 million   Price prior: $0.29   Shares: TBD   Underwriters: ThinkEquity;...
07:00 , May 31, 2010 |  BC Week In Review  |  Financial News

Salix completes private placement of senior convertible notes

Salix Pharmaceuticals Ltd. (NASDAQ:SLXP), Morrisville, N.C.   Business: Autoimmune, Infectious, Gastrointestinal   Date completed: 5/27/10   Type: Private placement of senior convertible notes   Raised: $300 million   Underwriters: Merrill Lynch; Jefferies; Caris & Co.;...
08:00 , Jan 18, 2010 |  BioCentury  |  Finance

Banker tracks

Robert Gaynor and Jim Love joined Madison Williams as managing directors in healthcare banking. David Moskowitz also joined as a managing director in research. With the hires, the firm announced the launch of its healthcare...
07:00 , Sep 22, 2008 |  BioCentury  |  Finance

Shaking in their shorts

Shaking in their shortsA handful of heavily shorted small cap biotechs got a bounce last week after the U.S. Securities and Exchange Commission announced new actions intended to eliminate "naked" short selling - the abusive...
07:00 , Sep 24, 2007 |  BioCentury  |  Finance

Ebb & Flow

Having chalked up a number of specialty pharma exits over the last few years, Domain Associates made another tidy exit last week, as urology and gynecology company Esprit is being acquired by Allergan (AGN) for...
07:00 , Jun 25, 2007 |  BioCentury  |  Finance

Ebb & Flow

Stocks generally fall to account for dilution when companies propose follow-ons. But shares of Transgene (Euro-next:Transgene) rose both before and after the company's offering last week. Generalist investors from across the continent with little exposure...
07:00 , Jun 11, 2007 |  BioCentury  |  Finance

Ebb & Flow

The Street had a mixed reaction to the pair of private companies that Amgen (AMGN) picked up last week. One of them seems to be a close fit with AMGN's existing products and sales strategy...
02:09 , Jun 6, 2007 |  BC Extra  |  Financial News

Response Genetics prices IPO

RGDX raised $21 million through the sale of 3 million shares at $7 in an IPO underwritten by Maxim Group and Caris & Co. The price was at the bottom of the company's proposed $7-$8...